Medical Device News Magazine

Global Wearable Injectors Market (2021 to 2026) – by Type, Technology, Application, End-user and Region

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The “Wearable Injectors Market By Type, By Technology, By Application, By End-User, And By Regions – Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2021 – 2026” report has been added to’s offering.

According to the report, the global wearable injectors market was valued at approximately USD 6.9 Billion in 2020 and is expected to reach a value of around USD 11.5 Billion by 2026, at a CAGR of around 8.9% between 2021 and 2026.

Wearable injectors are devices that can be worn on the body in the form of a patch or complete equipment for timely medicine inoculation. There are various kinds of medical condition in which timely injection of drugs are necessary for the normal functioning of the body when the person is affected from diabetes, Parkinson’s disease, heart disorders, and cancer. These products help the patient suffering from chronic diseases live a normal life. These devices can also be connected to the body in the form of a tube via a tiny discreet instrument. Moreover, wearable injectors also have wireless connectivity and their operations or functionalities can be regulated through software.

Rise in the occurrence of chronic ailments to drive the market expansion

The tremendous rise in the occurrence of chronic ailments like heart diseases, diabetes, and cancer will offer lucrative growth avenues for the market over the forecast timeline. According to the report of International Diabetes Federation, about 425 million persons were found be have been suffering from diabetes in 2017 and the figures are slated to hit nearly 629 million by 2045. Moreover, diabetic conditions need drug inoculation on time for maintaining normal body functioning. This will elevate the growth of the wearable injectors industry over the forecast timeline.

Furthermore, the launching of new technologies for maintaining the balance between disease management and lifestyles will further elevate the business growth during the forecast timeline. Moreover, technology has minimized the device size and made it user-friendly, thereby further accelerating the growth rate of the market over the forecast timeline. Nonetheless, growing acceptance of alternate modes of drug delivery will inhibit the scope of the market during the forecast timeframe.

On-body injectors to dominate the type segment by 2027

The users easily wear these devices and are handled by wireless connection & software. Moreover, technological breakthroughs have reduced the equipment size, thereby further steering the segmental growth over the forecast timeline.

Immuno-oncology segment to contribute majorly towards the overall market share by 2027

The growth of the segment during the forecast period is due to the high occurrence of cancer across the globe.

North America to lead the regional market growth during the period from 2019 to 2027

The growth of the market in North America is due to the presence of strong healthcare infrastructure along with growing incidences of chronic ailments. In addition to this, an increase in the research activities for biologics and the development of new injector design are a few of the major factors that are likely to steer the growth of the industry during the period from 2019 to 2027.

Furthermore, a rise in the acceptance of wearable injectors, favorable compensation policies, and bulge in healthcare spending are some of the aspects that will steer the regional market surge over the forecast timeline.

This report segments the Wearable Injectors market as follows:

Global Wearable Injectors Market: By Type Segment Analysis

  • On-Body
  • Off-Body

Global Wearable Injectors Market: By Technology Segment Analysis

  • Spring-Based
  • Motor-Driven
  • Rotary Pump
  • Expanding Battery
  • Others

Global Wearable Injectors Market: By Application Segment Analysis

  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Others

Global Wearable Injectors Market: By End-User Segment Analysis

  • Hospitals
  • Clinic
  • Home Care Settings
  • Others

Global Wearable Injectors Market: Regional Segment Analysis

  • North America
  • U.S.
  • Europe
  • UK
  • France
  • Germany
  • Asia Pacific
  • China
  • Japan
  • India
  • Latin America
  • Brazil
  • Middle East and Africa

Companies Mentioned

  • Becton
  • Dickinson and Company
  • Johnson & Johnson Services Inc.
  • F. Hoffman-La Roche Ltd.
  • Unilife Corporation
  • SteadyMed Therapeutics Inc.
  • Amgen Inc.
  • Insulet Corporation
  • Enable Injections
  • West Pharmaceuticals Services Inc.
  • CeQur S.A.
  • ATS Automation
  • Tandem Diabetes Care
  • Noble

For more information about this report visit here.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”